Societe Generale downgraded Eli Lilly to Sell from Hold with a $278 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on LLY:
- Eli Lilly’s (NYSE:LLY) Growth Slowdown Doesn’t Take Away from Its Bull Case
- Eli Lilly to supply API for insulin at reduced price to IABL
- Eli Lilly price target raised to $455 from $440 at Morgan Stanley
- Eli Lilly’s net price for Mounjaro did not decline in Q4, says Evercore ISI
- Pharma Earnings: Q4 Hits and Misses in a Post-COVID-19 World